ReviewJournal of hepatocellular carcinoma2026

Current Perspectives on the Use of Adjuvant Pembrolizumab for Hepatocellular Carcinoma.

Anna Mingazzini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.